Login / Signup

Sex differences of burosumab in children with X-linked hypophosphataemic rickets.

Guido FillerOlivia TremblayEmily ChenSusan Shi Han HuangRobert Stein
Published in: Pediatric nephrology (Berlin, Germany) (2022)
Our findings may suggest a sex difference in response to burosumab in XLH patients. Our data suggest that males may require higher doses.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • young adults
  • peritoneal dialysis
  • electronic health record
  • big data
  • patient reported outcomes